Type
. Thalidomide: a re-look. The National medical journal of India. 2000;13(3):132-41.
Type
. Update on leprosy. Hospital medicine (London, England : 1998). 2001;62(8):471-6.
Type
. Why are public-health policies ill made in japan?. Lancet (London, England). 2001;358(9281):589.
Type
. Presence of cytokines in the serum may affect the in vitro responses of T cells. Acta leprologica. 2000;12(1):5-6.
Type
. Comparative value of active and passive surveillance over time in treated leprosy patients, in the prevention of further disability. Leprosy review [Internet]. 2001;72(2):221-3. Available from: http://leprev.ilsl.br/pdfs/2001/v72n2/pdf/v72n2a13.pdf
Type
. Should nutritional status evaluation be included in the initial needs assessment of leprosy patients with disability prior to socio-economic. Leprosy review [Internet]. 2001;72(2):206-11. Available from: http://leprev.ilsl.br/pdfs/2001/v72n2/pdf/v72n2a11.pdf
Type
. Fine needle aspiration cytology (FNAC) of nerves in leprosy. Leprosy review [Internet]. 2001;72(2):171-8. Available from: http://leprev.ilsl.br/pdfs/2001/v72n2/pdf/v72n2a07.pdf
Type
. Dynamics of impairment during and after treatment: the AMFES cohort. Leprosy review [Internet]. 2001;72(2):158-70. Available from: http://leprev.ilsl.br/pdfs/2001/v72n2/pdf/v72n2a06.pdf
Type
. Cataract: the main cause of blindness in leprosy. Leprosy review [Internet]. 2001;72(2):139-42. Available from: http://leprev.ilsl.br/pdfs/2001/v72n2/pdf/v72n2a03.pdf
Type
. Effect of HIV infection on the clinical spectrum of leprosy in Maiduguri. The Nigerian postgraduate medical journal. 2001;8(2):74-7.